NEO

NEO Financing Cash Flow

-$11.39MTTM · USD

Period ending:

NEO FY Cash from FinancingUSD
NEO FY Cash from Financing2000-12-31: $133.70K2001-12-31: $157.31K2002-12-31: $725.58K2003-12-31: $620.61K2004-12-31: $831.56K2005-12-31: $918.08K2006-12-31: $1.21M2007-12-31: $3.44M2008-12-31: $897.69K2009-12-31: $3.63M2010-12-31: $2.43M2011-12-31: $2.36M2012-12-31: $3.38M2013-12-31: $2.75M2014-12-31: $29.01M2015-12-31: $58.49M2016-12-31: -$25.87M2017-12-31: -$4.10M2018-12-31: $91.96M2019-12-31: $159.47M2020-12-31: $235.60M2021-12-31: $725.29M2022-12-31: $11.83M2023-12-31: $4.55M2024-12-31: $4.65M2025-12-31: -$200.29M$725.29M-$200.29M
2000-12-312025-12-31

Source: Financial Modeling Prep (FMP). Annual fiscal periods; reported in USD. Dates are period ends; a fiscal year may differ from a calendar year.

NEO financing cash flow history

Cash from issuing/repaying debt and equity. The available annual fiscal periods series contains 26 observations from Dec 31, 2000 to Dec 31, 2025.

Neogenomics Inc Financing Cash Flow — Annual fiscal periods (USD)
Period endingFinancing Cash Flow (USD)
-200,288,000
4,646,000
4,554,000
11,829,000
725,285,000
235,597,000
159,466,000
91,959,000
-4,095,000
-25,871,000
58,493,000
29,007,000
2,750,000
3,384,000
2,359,000
2,434,000
3,627,055
897,685
3,443,042
1,207,722
918,075
831,562
620,605
725,579
157,314
133,704

Compare financing cash flow

All NEO financial metrics · NEO stock overview · How to interpret financial metrics

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.